Back to search
Menstrually Associated Migraine
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Menstrually Associated Migraine trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Menstrually Associated Migraine trials you may qualify forThe primary objective of this study was to determine whether frovatriptan was effective in the prevention of menstrually associated migraine (MAM) headaches whe…
In this open-label, multi-center study, patients were treated with frovatriptan for a maximum of 12 perimenstrual periods (PMPs). For each PMP, dosing commenced…
This study will examine the combined effects of a continuous oral contraceptive (OC) regimen with supplemental frovatriptan therapy on headache severity and occ…
This study will examine the combined effects of a continuous oral contraceptive (OC) regimen with supplemental estradiol therapy on headache severity and occurr…
The purpose of this trial is to study the use of soy isoflavones in the prevention of menstrually-associated migraines. Additionally, this trial may provide ins…